MedPath

MyMenoPlan: Online Resource for Improving Women's Menopause Knowledge and Informed Decision-making

Not Applicable
Completed
Conditions
Postmenopause
Menopause
Premenopause
Interventions
Other: Control
Other: MyMenoPlan
Registration Number
NCT05299983
Lead Sponsor
University of California, San Diego
Brief Summary

As part of a National Institute on Aging -funded R01, the investigators developed an evidence-based, multi-media digital resource entitled MyMenoPlan to help women learn about the menopause transition, and the symptoms and treatments of perimenopause/menopause. MyMenoPlan is also designed to help women learn about the effectiveness of treatments for a comprehensive list of midlife symptoms and compare treatments that may help with the specific symptoms women are experiencing.

Detailed Description

The purpose of this research study is to:

1. Investigate how women randomly assigned to visit MyMenoPlan use the website (time spent on website, treatment and symptom page views, use of interactive tools, and use of the MyMenoPlan tool).

2. Compare the ratings of women randomly assigned to MyMenoPlan to those randomly assigned to other menopause websites for perceived quality of information, readability, self-efficacy, and credibility of these online menopause resources.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
410
Inclusion Criteria
  • As stated above
Exclusion Criteria
  • N/A

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ControlControlParticipants are asked to spend at least 20 minutes on at least one of the following websites or other websites of their choice: 1. North American Menopause Society: https://www.menopause.org/for-women 2. National Institute on Aging: https://www.nia.nih.gov/health/topics/menopause 3. The Office on Women's Health-Menopause: https://www.womenshealth.gov/menopause
MyMenoPlanMyMenoPlanParticipants are asked to spend at least 20 minutes on the website (MyMenoPlan) assigned to them.
Primary Outcome Measures
NameTimeMethod
Self-Efficacy for Managing Menopause SymptomsEach survey question is answered after spending at least 20 minutes on the assigned website(s)

This is a newly developed Likert scale (1- Strongly disagree to 5 - Strongly agree) for assessing participants' beliefs in their own abilities in managing menopausal symptoms. The range of this scale is 1-5. The items in this scale were averaged with a higher score meaning higher on this outcome (self-efficacy).

Items:

1. If I want to, I am certain I could figure out the treatments or coping strategies that would work best for me.

2. I feel I could treat or cope with my symptoms of perimenopause/menopause if I want to.

CredibilityEach survey question is answered after spending at least 20 minutes on the assigned website(s)

This 2-item, 5-point Likert (1- Strongly disagree to 5 - Strongly agree) scale was derived from the Standardized User Experience Percentile Rank Questionnaire (SUPR-Q) in Sauro (1995). The range of this scale is 1-5. The items in this scale were averaged with a higher score meaning higher on this outcome (credibility).

Items:

1. The information is credible.

2. The information is trustworthy.

ReadabilityEach survey question is answered after spending at least 20 minutes on the assigned website(s)

This 2-item, 5-point Likert (1- Strongly disagree to 5 - Strongly agree)scale was derived from the Standardized User Experience Percentile Rank Questionnaire (SUPR-Q) in Sauro (1995). The range of this scale is 1-5. The items in this scale were averaged with a higher score meaning higher on this outcome (readability).

Items:

1. The information I read was clear.

2. The information I read was easy for me to understand.

Perceived Quality of InformationEach survey question is answered after spending at least 20 minutes on the assigned website(s)

This 7-item, 5-point Likert scale (1- Strongly disagree to 5 - Strongly agree) is adapted from the Post-Study System Usability Questionnaire (PSSUQ) in Lewis (1995). The range of this scale is 1-5. The items in this scale were averaged with a higher score meaning higher on this outcome (perceived quality of information).

Items:

1. Reading the information made me feel in more control of my perimenopause/menopause.

2. The information on the website(s) was helpful to me.

3. I found the information I was looking for.

4. The information answered my questions about perimenopause/menopause.

5. I liked the website (s).

6. I would have liked more in-depth information. (reverse-coded)

7. The website(s) were fairly comprehensive about perimenopause /menopause.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

UC San Diego

🇺🇸

La Jolla, California, United States

© Copyright 2025. All Rights Reserved by MedPath